
HTA goes global
06/10/2020 Author: root_d8k2o428
In May this year, a new definition of HTA was announced following a collaboration co-led by the International Network of Agencies for HTA (INAHTA) and HTA International (HTAi).This…
Read More
Current biosimilar initiatives in Australia and Canada
02/10/2020 Author: root_d8k2o428
Ceperaec temperi bustius, this is an external link. Nam que nistore nectemperum accullest, omnisci a doloreium sitia solupta sum et aut es qui doluptati nus et lab illa simusdam…
Read More
Current biosimilar initiatives in Australia and Canada
04/08/2020 Author: root_d8k2o428
Over the past five years, a number of ‘big brand’ biologics have gone off patent and have been replaced with biosimilars. This remains a challenge for any biologic nearing the…
Read More
June: A global snapshot of COVID-19 – Part 2
01/07/2020 Author: root_d8k2o428
At the end of April, we published a summary of the global response to COVID-19 as written by a selection of FingerPost’s Global Associates who specialise in Market Access across different…
Read More
Focus on Japan: Reimbursement decisions from January – May 2020
31/05/2020 Author: root_d8k2o428
Pricing The highlight of the first quarter of 2020 was the bi-annual revision of National Health Insurance (NHI) prices and of medical fees, announced in March and coming into effect…
Read More